Anders Rodell
Aarhus University Hospital
40 Papers
400 Citations
Anders Rodell is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Cerebral blood flow & Temporal cortex. The author has an hindex of 19, co-authored 40 publications. Previous affiliations of Anders Rodell include University of Copenhagen & University of Queensland.
Chat about Author
Papers
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Michael Gejl,Albert Gjedde,Lærke Egefjord,Lærke Egefjord,Arne Møller,Søren B. Hansen,Kim Vang,Anders Rodell,Hans Brændgaard,Hanne Gottrup,Anna C. Schacht,Niels Møller,Birgitte Brock,Jørgen Rungby +13 more
TL;DR: It is concluded that the GLP-1 analog treatment prevented the decline of CMRglc that signifies cognitive impairment, synaptic dysfunction, and disease evolution in Alzheimer’s disease.
Brain Energy Metabolism and Blood Flow Differences in Healthy Aging
Joel Aanerud,Per Borghammer,M. Mallar Chakravarty,Kim Vang,Anders Rodell,Kristjana Y. Jonsdottir,Arne Møller,Arne Møller,Mahmoud Ashkanian,Mahmoud Ashkanian,Manouchehr Seyedi Vafaee,Manouchehr Seyedi Vafaee,Peter Iversen,Peter Johannsen,Albert Gjedde +14 more
TL;DR: A possible mechanism of progression from healthy to unhealthy brain aging is established, as the regions most affected by age are the areas that are most vulnerable to neurodegeneration.
178
Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients
Johan Stender,Ron Kupers,Anders Rodell,Aurore Thibaut,Camille Chatelle,Marie-Aurélie Bruno,Michael Gejl,Claire Bernard,Roland Hustinx,Steven Laureys,Albert Gjedde +10 more
TL;DR: Receiver-operating characteristics showed that patients in MCS and VS/UWS can be differentiated with 82% accuracy, based on cortical metabolism, suggesting that quantitative values of CMRglc reveal consciousness in severely brain-injured patients.
A deformation-based morphometry study of patients with early-stage Parkinson's disease.
Per Borghammer,Karen Østergaard,Paul Cumming,Albert Gjedde,Anders Rodell,Nicoline Marie Hall,M. Mallar Chakravarty,M. Mallar Chakravarty +7 more
TL;DR: Deformation‐based morphometry (DBM), a method purported to be more sensitive than VBM, is used to test for atrophy in patients with early‐stage PD.
96
The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers.
Erik H. Danielsen,Paul Cumming,Flemming L. Andersen,D. Bender,Thomas Brevig,Lise Falborg,Antony D. Gee,Nic Gillings,Søren B. Hansen,Flemming Hermansen,J Johansen,Teit E. Johansen,A. Dahl-Jørgensen,Jørgensen Ha,Morten Meyer,Ole Lajord Munk,Erik B. Pedersen,P. H. Poulsen,Anders Rodell,Masaharu Sakoh,Claus Z Simonsen,D. F. Smith,Jan Corfixen Sørensen,Ostergård L,Jens Zimmer,Albert Gjedde,Arne Møller +26 more
TL;DR: Preliminary results are suggestive that the activity of DOPA decarboxylase may be upregulated in the partially denervated pig striatum, suggestive of a stable parkinsonian syndrome established by MPTP intoxication of adult male Göttingen minipigs.
69